“adalimumab-humira” Archives

in
Entry Author Date Location
$5.8B for Nothing: AbbVie Shelves Stemcentrx Drug After Latest Flop 08/29/19 Detroit Ann Arbor
Bio Roundup: Leiden’s Exit, Depression Data, a New Pricing Bill & More 07/26/19 National
Bio Roundup: Array Bio Acquired, IPO Spree, Sanofi’s Job Cuts & More 06/21/19 National
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More 04/26/19 National
Safety Concerns Linger for Lilly’s Arthritis Drug as FDA Panel Looms 04/19/18 Indiana
Eli Lilly Builds Case to Expand Immune Drug’s Use to Spinal Arthritis 02/13/18 Indiana
Eli Lilly Preps Rejected Rheumatoid Arthritis Drug for Resubmission 08/30/17 Indiana
Gilman Scores for Atlas Again as Bristol Buys Padlock for up to $600M 03/23/16 Boston
Bird Rock Bio Nears Pivotal Trial of New Biologic Drug for RA 03/16/16 San Diego
Page 1 of 1

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Carbonite
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.

© 2007-2019, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.